Next Article in Journal
The Evolving Treatment Landscape of Hepatocellular Carcinoma: More Choices, More Responsibility
Previous Article in Journal
Expression of PD-L1 for Predicting Response to Immune Checkpoint Inhibitors in Metastatic Urothelial Carcinoma: A Systematic Review and Meta-Analysis
 
 
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Conference Report

Abstracts Submitted to the Cell Therapy Transplant Canada 2020 Annual Conference

301–750 W Pender Street, Vancouver, BC V6C 2T7, Canada
Curr. Oncol. 2020, 27(6), 664-684; https://doi.org/10.3747/co.27.7151
Submission received: 1 September 2020 / Revised: 4 October 2020 / Accepted: 7 November 2020 / Published: 1 December 2020

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

Cell Therapy Transplant Canada thanks the following sponsors for providing educational grants to publish the cttc 2020 abstracts in Current Oncology: [...]

Share and Cite

MDPI and ACS Style

Torres, A. Abstracts Submitted to the Cell Therapy Transplant Canada 2020 Annual Conference. Curr. Oncol. 2020, 27, 664-684. https://doi.org/10.3747/co.27.7151

AMA Style

Torres A. Abstracts Submitted to the Cell Therapy Transplant Canada 2020 Annual Conference. Current Oncology. 2020; 27(6):664-684. https://doi.org/10.3747/co.27.7151

Chicago/Turabian Style

Torres, Ana. 2020. "Abstracts Submitted to the Cell Therapy Transplant Canada 2020 Annual Conference" Current Oncology 27, no. 6: 664-684. https://doi.org/10.3747/co.27.7151

Article Metrics

Back to TopTop